Page last updated: 2024-08-23

daunorubicin and Cutaneous T-Cell Lymphoma

daunorubicin has been researched along with Cutaneous T-Cell Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alonso-Llamazares, J; Marchione, R; Ricotti, C; Romanelli, P; Shiman, M1
Haroske, E; Hohaus, K; Köstler, E; Schönlebe, J; Wollina, U1

Reviews

1 review(s) available for daunorubicin and Cutaneous T-Cell Lymphoma

ArticleYear
CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine

2008

Other Studies

1 other study(ies) available for daunorubicin and Cutaneous T-Cell Lymphoma

ArticleYear
Liposomal daunorubicin in tumor stage cutaneous T-cell lymphoma: report of three cases.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Female; Humans; Liposomes; Lymphoma, T-Cell, Cutaneous; Male; Treatment Outcome

2003